These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34636915)

  • 21. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Online prostate cancer screening decision aid for at-risk men: a randomized trial.
    Watts KJ; Meiser B; Wakefield CE; Barratt AL; Howard K; Cheah BC; Mann GJ; Lobb EA; Gaff CL; Patel MI
    Health Psychol; 2014 Sep; 33(9):986-97. PubMed ID: 24274808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.
    Auvinen A; Rannikko A; Taari K; Kujala P; Mirtti T; Kenttämies A; Rinta-Kiikka I; Lehtimäki T; Oksala N; Pettersson K; Tammela TL
    Eur J Epidemiol; 2017 Jun; 32(6):521-527. PubMed ID: 28762124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins.
    Vettenranta A; Murtola TJ; Raitanen J; Raittinen P; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    JAMA Oncol; 2022 Jan; 8(1):61-68. PubMed ID: 34817559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability.
    Scalia P; Durand MA; Faber M; Kremer JA; Song J; Elwyn G
    BMJ Open; 2019 May; 9(5):e026748. PubMed ID: 31133587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.
    Allen JD; Reich A; Cuevas AG; Ladin K
    JMIR Mhealth Uhealth; 2020 May; 8(5):e15502. PubMed ID: 32369032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.
    Vernooij RWM; Lytvyn L; Pardo-Hernandez H; Albarqouni L; Canelo-Aybar C; Campbell K; Agoritsas T
    BMJ Open; 2018 Sep; 8(9):e025470. PubMed ID: 30185585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
    Murtola TJ; Vettenranta AM; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2018 Dec; 4(6):851-857. PubMed ID: 28753870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
    Chan EC; McFall SL; Byrd TL; Mullen PD; Volk RJ; Ureda J; Calderon-Mora J; Morales P; Valdes A; Kay Bartholomew L
    Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Value Prostate-Specific Antigen Screening in Older Males.
    Kalavacherla S; Riviere P; Javier-DesLoges J; Banegas MP; McKay RR; Murphy JD; Rose BS
    JAMA Netw Open; 2023 Apr; 6(4):e237504. PubMed ID: 37040113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Bennett CL; Barry MJ; Col NF; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Légaré F; Thomson R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD001431. PubMed ID: 21975733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Bokhorst LP; Bangma CH; van Leenders GJ; Lous JJ; Moss SM; Schröder FH; Roobol MJ
    Eur Urol; 2014 Feb; 65(2):329-36. PubMed ID: 23954085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.
    Wheeler DC; Szymanski KM; Black A; Nelson DE
    BMC Cancer; 2011 Apr; 11():148. PubMed ID: 21510865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
    Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Grönberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum KU; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM;
    BMJ; 2018 Jan; 360():j5757. PubMed ID: 29321194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.
    Rychetnik L; Doust J; Thomas R; Gardiner R; Mackenzie G; Glasziou P
    BMJ Open; 2014 Apr; 4(4):e004682. PubMed ID: 24785399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
    Harrison S; Tilling K; Turner EL; Lane JA; Simpkin A; Davis M; Donovan J; Hamdy FC; Neal DE; Martin RM
    Cancer Causes Control; 2016 Dec; 27(12):1465-1474. PubMed ID: 27830401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial.
    Smith SK; Trevena L; Simpson JM; Barratt A; Nutbeam D; McCaffery KJ
    BMJ; 2010 Oct; 341():c5370. PubMed ID: 20978060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.
    Landrey AR; Matlock DD; Andrews L; Bronsert M; Denberg T
    J Prim Care Community Health; 2013 Jan; 4(1):67-74. PubMed ID: 23799692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.